Related Experiment Videos
Size-dependent DNA mobility in cytoplasm and nucleus.
G L Lukacs1, P Haggie, O Seksek
1Departments of Medicine and Physiology, Cardiovascular Research Institute, University of California, San Francisco, California 94143-0521, USA.
The Journal of Biological Chemistry
|January 15, 2000
Summary
DNA diffusion in cytoplasm significantly hinders gene delivery. Larger DNA fragments (>250 bp) exhibit restricted mobility due to molecular crowding, impacting therapeutic efficacy.
Area of Science:
- Cellular and Molecular Biology
- Biophysics
- Gene Therapy
Background:
- DNA diffusion in the cytoplasm is crucial for gene delivery and antisense therapy efficacy.
- Understanding DNA's movement within cells is key to optimizing therapeutic strategies.
Purpose of the Study:
- To quantify the translational diffusion of double-stranded DNA fragments of varying sizes within HeLa cell cytoplasm and nucleus.
- To compare DNA diffusion rates with those of dextrans and to elucidate the factors limiting DNA mobility.
Main Methods:
- Microinjection of fluorescein-labeled double-stranded DNA fragments (21-6000 bp) into HeLa cells.
- Measurement of diffusion coefficients using spot photobleaching with a focused argon laser.
- Comparison of DNA diffusion with fluorescein isothiocyanate (FITC) dextran diffusion.
Main Results:
- DNA diffusion coefficients in aqueous solution decreased with increasing DNA size (21-6000 bp).
- Cytoplasmic DNA diffusion was significantly lower than in aqueous solution, decreasing with size and strongly influenced by molecular crowding.
- DNA fragments (>250 bp) showed markedly reduced diffusion in cytoplasm compared to FITC dextrans.
- DNA fragments were nearly immobile in the nucleus, unlike mobile FITC dextrans.
Conclusions:
- Extensive binding to immobile obstacles restricts DNA diffusion in the nucleus.
- Molecular crowding in the cytoplasm limits the lateral mobility of DNA fragments larger than 250 bp.
- DNA diffusion in the cytoplasm represents a potential rate-limiting barrier for non-viral gene delivery vectors.